Does ZANUBRUTINIB Cause Epistaxis? 37 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Epistaxis have been filed in association with ZANUBRUTINIB (BRUKINSA). This represents 1.3% of all adverse event reports for ZANUBRUTINIB.
37
Reports of Epistaxis with ZANUBRUTINIB
1.3%
of all ZANUBRUTINIB reports
3
Deaths
14
Hospitalizations
How Dangerous Is Epistaxis From ZANUBRUTINIB?
Of the 37 reports, 3 (8.1%) resulted in death, 14 (37.8%) required hospitalization, and 2 (5.4%) were considered life-threatening.
Is Epistaxis Listed in the Official Label?
Yes, Epistaxis is listed as a known adverse reaction in the official FDA drug label for ZANUBRUTINIB.
What Other Side Effects Does ZANUBRUTINIB Cause?
Off label use (376)
Disease progression (224)
Contusion (165)
Myelosuppression (147)
Fatigue (146)
Rash (134)
Death (120)
White blood cell count decreased (119)
Platelet count decreased (112)
Anaemia (102)
What Other Drugs Cause Epistaxis?
RIVAROXABAN (5,629)
ASPIRIN (3,214)
APIXABAN (2,831)
FLUTICASONE (1,745)
TREPROSTINIL (1,726)
CLOPIDOGREL BISULFATE (1,560)
BEVACIZUMAB (1,542)
WARFARIN (1,498)
PALBOCICLIB (1,280)
ADALIMUMAB (1,243)
Which ZANUBRUTINIB Alternatives Have Lower Epistaxis Risk?
ZANUBRUTINIB vs ZAVEGEPANT
ZANUBRUTINIB vs ZEAXANTHIN
ZANUBRUTINIB vs ZELBORAF
ZANUBRUTINIB vs ZEMPLAR
ZANUBRUTINIB vs ZENATANE